|
|
| (11) | Number of the document | C 1480644 |
| (68) | Number of the document | 1480644 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 037 |
| (22) | Date of filing the application | 2016-12-13 |
| (41) | Date of publication of the application | 2017-01-10 |
| Date of publication of SPC | 2018-09-10 | |
| (24) | Date of coming into effect of SPC | 2023-01-28 |
| (71) |
ASTRA ZENECA HOLDING FRANCE,
,
|
| (73) |
Pfizer Ireland Pharmaceuticals Unlimited Company,
Operations Support Group Ringaskiddy, Co.Cork,
IE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | EU/1/16/1109/001, 2016-06-24 |
| (94) | 2028-01-27 |
| (95) | Farmacinis mišinys arba derinys, apimantis kaip veikliuosius ingredientus (1) ceftazidimą arba jo druską ir (2) avibaktamą arba jo druską |
| Request filed | SPC extension granted until | Request refused | |
| 2025-06-10 | 2028-07-27 |
| Payment date | Validity (years) | Amount | |
| 2025-12-19 | 4 | 347.00 EUR |
| 2027-01-28 |
| SPC term extension granted |